Fosamax Lawyers at Bernstein Liebhard LLP Note Upcoming Case Management Conference in New Jersey Fosamax Litigation

Share Article

Bernstein Liebhard LLP is currently evaluating Fosamax lawsuits on behalf of individuals who suffered atypical femur fractures allegedly due to their use of the drug.

Bernstein Liebhard LLP | Consumer Injury Lawyers
We are pleased to see this litigation progressing. Our Firm continues to hear from individuals who have suffered from debilitating femur fractures that could be associated with long-term use of Fosamax.

The Fosamax lawyers at Bernstein Liebhard LLP continue to follow developments in the ongoing Fosamax litigation now underway in New Jersey Superior Court, Atlantic County. According to court documents, the litigation’s next case management conference has been scheduled for March 12th. As of February 23, 2013, 2,553 Fosamax lawsuits had been filed in Atlantic County by Plaintiffs who claim to have suffered femur fractures and other side effects due to Fosamax.

“We are pleased to see this litigation progressing. Our Firm continues to hear from individuals who have suffered from debilitating femur fractures that could be associated with long-term use of Fosamax,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Fosamax femur fractures.

Fosamax Femur Fractures
Fosamax belongs to a class of medications called bisphosphonates, and is used to prevent osteoporosis in post-menopausal women. In October 2010, the U.S. Food & Drug Administration (FDA) added new information to the Fosamax label after studies indicated that people taking bisphosphonates for osteoporosis are at risk of suffering atypical femur fractures.* Most recently, an FDA-commissioned analysis published in the New England Journal of Medicine last May found that there was little benefit in taking bisphosphonates for longer than five years due to their association with serious side effects, including atypical femur fractures.**

In addition to the litigation underway in New Jersey Superior Court, additional Fosamax lawsuits involving femur facture allegations have been consolidated in a multidistrict litigation in U.S. District Court, District of New Jersey (In re: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II) - MDL No. 2243). According to court records, the first femur fracture trials in both the state and federal Fosamax litigations are expected to begin later this year.

Victims of femur fractures that might be associated with the use of Fosamax may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. A wealth of information regarding Fosamax lawsuits is available by visiting Bernstein Liebhard LLP’s website, http://www.consumerinjurylawyers.com/. To arrange for a free case review, please contact Bernstein Liebhard LLP at (877) 779-1414.

*fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229171.htm
**nejm.org/doi/full/10.1056/NEJMp1202619

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website